Clinical Trials Related to Zealand Pharma

Related studies linked through entity extraction aliases.

Multiple Ascending Doses of ZP4207 Administered to HV to Evaluate the Safety, Tolerability, PKs and PDs of ZP4207

Status: COMPLETED
Phase: PHASE1

Single Ascending Doses of ZP4207 Administered in HV and in T1D to Evaluate Safety, Tolerability PKs and PDs of ZP4207 Compared to a Comparator

Status: COMPLETED
Phase: PHASE1

Study of Immune Cells in Obese Patients With Type 2 Diabetes Mellitus Treated With Liraglutide

Status: COMPLETED
Phase: N/A

Phase 2 Clinical Proof-of-Concept Study of the Cardioprotective Properties of Danegaptide in ST Segment Elevation Myocardial Infarction

Status: COMPLETED
Phase: PHASE2

Healthy Normal Single Ascending Dose and Crohn's Patient Multiple Ascending Dose

Status: COMPLETED
Phase: PHASE1

ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure

Status: TERMINATED
Phase: PHASE2